Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling
出版年份 2021 全文链接
标题
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling
作者
关键词
-
出版物
NATURE CELL BIOLOGY
Volume 23, Issue 4, Pages 377-390
出版商
Springer Science and Business Media LLC
发表日期
2021-04-02
DOI
10.1038/s41556-021-00654-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
- (2020) Sanne C. F. A. Huijberts et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer
- (2020) Vito Amodio et al. Cancer Discovery
- Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype
- (2020) Barbara Lupo et al. Science Translational Medicine
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
- (2019) Ye Yao et al. Cell Stem Cell
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- A rectal cancer organoid platform to study individual responses to chemoradiation
- (2019) Karuna Ganesh et al. NATURE MEDICINE
- KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
- (2018) Chiara Ambrogio et al. CELL
- SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
- (2018) Sara Mainardi et al. NATURE MEDICINE
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Afatinib restrains K-RAS–driven lung tumorigenesis
- (2018) Herwig P. Moll et al. Science Translational Medicine
- Composite regulation of ERK activity dynamics underlying tumour-specific traits in the intestine
- (2018) Yu Muta et al. Nature Communications
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Intra-tumour diversification in colorectal cancer at the single-cell level
- (2018) Sophie F. Roerink et al. NATURE
- RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
- (2018) Robert J. Nichols et al. NATURE CELL BIOLOGY
- Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway
- (2018) L. J. Bugaj et al. SCIENCE
- Therapeutic strategies to target RAS-mutant cancers
- (2018) Meagan B. Ryan et al. Nature Reviews Clinical Oncology
- Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
- (2017) Andrew M. Waters et al. Science Signaling
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- (2017) Chantal Pauli et al. Cancer Discovery
- A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
- (2017) Robin M.J.M. van Geel et al. Cancer Discovery
- Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
- (2017) Andrew M. Waters et al. Science Signaling
- Linear Integration of ERK Activity Predominates over Persistence Detection in Fra-1 Regulation
- (2017) Taryn E. Gillies et al. Cell Systems
- A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
- (2016) Masayuki Fujii et al. Cell Stem Cell
- Metabolism, Excretion, and Pharmacokinetics of Selumetinib, an MEK1/2 inhibitor, in Healthy Adult Male Subjects
- (2016) Angela W. Dymond et al. CLINICAL THERAPEUTICS
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
- (2016) Carla S Verissimo et al. eLife
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Receptor Level Mechanisms Are Required for Epidermal Growth Factor (EGF)-stimulated Extracellular Signal-regulated Kinase (ERK) Activity Pulses
- (2015) Breanne Sparta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
- (2015) J. C. Hunter et al. MOLECULAR CANCER RESEARCH
- Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
- (2015) Mami Matano et al. NATURE MEDICINE
- Regulation of RAF protein kinases in ERK signalling
- (2015) Hugo Lavoie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
- (2015) Eugenia R. Zanella et al. Science Translational Medicine
- Quantitative analysis of recombination between YFP and CFP genes of FRET biosensors introduced by lentiviral or retroviral gene transfer
- (2015) Akira T. Komatsubara et al. Scientific Reports
- Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin
- (2015) Toru Hiratsuka et al. eLife
- The FRET Signatures of Noninteracting Proteins in Membranes: Simulations and Experiments
- (2014) Christopher King et al. BIOPHYSICAL JOURNAL
- High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells
- (2014) Sergi Regot et al. CELL
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- Stochastic ERK Activation Induced by Noise and Cell-to-Cell Propagation Regulates Cell Density-Dependent Proliferation
- (2013) Kazuhiro Aoki et al. MOLECULAR CELL
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
- (2012) Carolina Navas et al. CANCER CELL
- EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
- (2012) Christine M. Ardito et al. CANCER CELL
- Live Imaging of Protein Kinase Activities in Transgenic Mice Expressing FRET Biosensors
- (2012) Yuji Kamioka et al. CELL STRUCTURE AND FUNCTION
- Frequency-Modulated Pulses of ERK Activity Transmit Quantitative Proliferation Signals
- (2012) John G. Albeck et al. MOLECULAR CELL
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%
- (2012) Joachim Goedhart et al. Nature Communications
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
- (2011) Rafael B. Blasco et al. CANCER CELL
- Development of an optimized backbone of FRET biosensors for kinases and GTPases
- (2011) Naoki Komatsu et al. MOLECULAR BIOLOGY OF THE CELL
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
- (2011) Kristen L. Meerbrey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Briefly Bound to Activate: Transient Binding of a Second Catalytic Magnesium Activates the Structure and Dynamics of CDK2 Kinase for Catalysis
- (2011) Zhao Qin Bao et al. STRUCTURE
- Mechanism of PhosphoThreonine/Serine Recognition and Specificity for Modular Domains from All-atom Molecular Dynamics
- (2011) Yu-ming M Huang et al. BMC Biophysics
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Distinct Pools of cdc25C Are Phosphorylated on Specific TP Sites and Differentially Localized in Human Mitotic Cells
- (2010) Celine Franckhauser et al. PLoS One
- Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution
- (2009) L. J. Holt et al. SCIENCE
- Differential phosphorylation of Cdc25C phosphatase in mitosis
- (2008) Jérôme Bonnet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A genetically encoded fluorescent sensor of ERK activity
- (2008) C. D. Harvey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now